Looking to publish in JAIDS Journal of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginJAIDS Journal of Acquired Immune Deficiency Syndromes is a journal focused on HIV/AIDS and related research. It publishes 12 issues per year and lists an Impact Factor of 2.2. The journal highlights clinical science, epidemiology, prevention research, implementation science, critical reviews, letters to the editor, and supplements, and it offers an open access publishing option.
Looking to publish in JAIDS Journal of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
JAIDS Journal of Acquired Immune Deficiency Syndromes accepts the following article types. Click on an article type to view submission instructions.
Basic Science
Clinical Science
Translational Research
Epidemiology
Implementation Science
Prevention Research
Critical Review
Original Articles
Rapid Communications
Brief Reports
Letters To The Editor
Recent Publications
Statin Prescribing and Guideline Concordance Among Adults With HIV Aged 40–75 Years in a Single Urban Outpatient HIV Clinic, 2024
Ana Khazan, Andrea M. Pallotta, Deepali Boothankad Sharath, Bethany Lehman
Emerging non-AIDS comorbidities among adults with and without perinatally-acquired HIV
Patrick Ryscavage, Jeffrey Fenn, Devang Patel, Hegang Chen
Unhealthy alcohol use’s impact on clinical pharmacist-delivered tobacco treatment among persons with HIV: An exploratory analysis of a randomized clinical trial
E. Jennifer Edelman, Yanhong Deng, James Dziura, June Weiss, Krysten Bold, Sherry Aiudi, Lydia Aoun-Barakat, Dini Harsono, Colleen Mistler, Erika Payne, Manisha Gupta, Keith Sigel, Jessica E. Yager, Inbal Nahum-Shani, David M. Ledgerwood, Steven L. Bernstein
Improved Pregnancy Viral Load Monitoring but Persistent Postpartum Gaps After Guideline Changes: A Population-Based Analysis in the Western Cape, South Africa (2018–2024)
Kim Anderson, Emma Kalk, Tamsin Kate Phillips, Nisha Jacob, Florence Phelanyane, Jonathan Euvrard, Juanita Arendse, Aurelie Nelson, Muzzammil Ismail, Andrew Boulle, Mary-Ann Davies
Cross-sectional Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Estimates in a U.S. Cohort of Black and Latina Transgender Women with HIV
Megan Zheng, Molly Ehrig, Hayley E. Cunningham, L. Zachary DuBois, Robert-Paul Juster, Sari L. Reisner, Andrea L. Wirtz, Asa E. Radix, Jowanna Malone, Kenneth Mayer, Carl Streed, Mabel Toribio, Ashleigh J. Rich, Bridget Dobson, Tonia Poteat
Frequently asked questions
How long does it take to publish?
Rapid Communications will normally be published within 8 weeks of acceptance. The editorial office will acknowledge receipt of the manuscript via e-mail. Authors reviewing Rapid Communications proofs are expected to return corrections within 24 hours of receipt.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite PremiumIs a cover letter required?
A cover letter is requested for Rapid Communications to explain why the paper merits special attention.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite PremiumWhat are the publication costs?
Hybrid open access is available with an APC charged on acceptance and payable within 30 days. Eligible corresponding authors at participating institutions may receive a $0.00 APC under read-and-publish agreements.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite Premium